APRI (Aprinoia Therapeutics) Research & Development: $16.98 Mil (TTM As of Dec. 2023)


What is Aprinoia Therapeutics Research & Development?

Aprinoia Therapeutics APRI Research & Development is $16.98 Mil as of Dec. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. Aprinoia Therapeutics's Research & Development for the six months ended in Dec. 2023 was $5.91 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $16.98 Mil.

Aprinoia Therapeutics  (NAS:APRI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aprinoia Therapeutics Research & Development Related Terms

Aprinoia Therapeutics Research & Development Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Research & Development Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
19.66 21.62 16.98

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development 0.00 11.29 10.33 11.07 5.91

Aprinoia Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $16.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $16.98 Mil mean?
Aprinoia Therapeutics (APRI) has a Research & Development of $16.98 Mil as of Dec. 2023. Research and development expense is the total cost for research and development activities. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Research & Development too high?
Aprinoia Therapeutics' current Research & Development is $16.98 Mil.
How does Aprinoia Therapeutics' Research & Development compare to ?
Aprinoia Therapeutics' Research & Development of $16.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Research & Development is $16.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Research & Development of $16.98 Mil. The current Research & Development is $16.98 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Research & Development is $16.98 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.